# Amphastar Pharmaceuticals, Inc. (AMPH)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AMPH)

## Price

| Indicator | Value |
| --- | --- |
| Market Cap | $ 952.41M |

## Valuation

| Indicator | Value |
| --- | --- |
| P/E10 | 13.71 |
| P/FCF10 | 13.07 |
| PEG | 0.33 |
| PFCF-PEG | 0.28 |

Widest P/E window this company has the history to fill: 13 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.90 |
| Liabilities / Eq | 1.27 |
| Current Ratio | 2.40 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 9.91 |
| Gross Debt / FCF | 9.44 |

## Other views

- [Charts](https://sponda.capital/en/AMPH/charts.md)
- [Fundamentals](https://sponda.capital/en/AMPH/fundamentals.md)
- [Compare](https://sponda.capital/en/AMPH/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.